Now opioid users can qualify for MMP
Gov. Phil Murphy announced Tuesday several immediate changes that will allow New Jersey’s medicinal marijuana program to expand far beyond the 18,500 patients who are enrolled now. The biggest change: people with specific kinds of chronic pain, anxiety, migraines and Tourette’s syndrome may ask their doctor to recommend them to the program.
Here’s a quick look at what’s changed and how it may affect you.
Q: What are the medical conditions that qualify a person for the program?
Before Tuesday, and still in effect:
- Amyotrophic lateral sclerosis (Lou Gehrig’s disease);
- multiple sclerosis;
- terminal cancer;
- muscular dystrophy;
- inflammatory bowel disease including Crohn’s disease;
- any terminal illness with a prognosis of less than 12 months;
- seizure disorders including epilepsy, intractable skeletal muscular spasticity, post-traumatic stress disorder and glaucoma qualify if traditional medicine has failed;
- Severe or chronic pain, severe nausea or vomiting and wasting syndrome caused by HIV/AIDS and cancer.
Since Murphy’s announcement, these were immediately added:
- Tourette’s syndrome;
- Chronic pain related to musculoskeletal disorders, which include rheumatoid arthritis, lupus, fibromyalgia and opioid use disorder;
- Chronic pain affecting internal organs, such as pancreatitis, irritable bowel syndrome, and neurogenic bladder and bowel dysfunction.